ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

292 hedge funds and large institutions have $10.9B invested in Alnylam Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 114 increasing their positions, 83 reducing their positions, and 34 closing their positions.

Holders
292
Holders Change
+10
Holders Change %
+3.55%
% of All Funds
6.7%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.28%
New
47
Increased
114
Reduced
83
Closed
34
Calls
$109M
Puts
$105M
Net Calls
+$3.5M
Net Calls Change
-$17.1M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$108M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.14B
3
FCM
3
Farallon Capital Management
California
$44.1M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$1.5B
5
O
5
OrbiMed
New York
$151M

Top Sellers

1
Dodge & Cox
1
Dodge & Cox
California
$559M
2
BRC
2
Blue Ridge Capital
New York
$0
3
ACH
3
ArrowMark Colorado Holdings
Colorado
$4.31M
4
Federated Hermes
4
Federated Hermes
Pennsylvania
$47.8M
5
Goldman Sachs
5
Goldman Sachs
New York
$120M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.79B 15,025,708 +150,087 +1%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$1.5B 12,569,334 +336,093 +3%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$1.14B 9,603,162 +420,632 +5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$887M 7,443,406 +179,492 +2%
BlackRock
5
BlackRock
New York
$855M 7,178,062 +62,999 +0.9%
Dodge & Cox
6
Dodge & Cox
California
$559M 4,692,841 -3,538,754 -43%
Baillie Gifford & Co
7
Baillie Gifford & Co
United Kingdom
$457M 3,834,213 +223,199 +6%
State Street
8
State Street
Massachusetts
$254M 2,131,817 +129,428 +6%
UBS AM
9
UBS AM
Illinois
$160M 1,341,171 -53,042 -4%
PA
10
Perceptive Advisors
New York
$153M 1,280,802 -50,000 -4%
O
11
OrbiMed
New York
$151M 1,265,966 +324,366 +34%
Morgan Stanley
12
Morgan Stanley
New York
$150M 1,260,423 +91,652 +8%
GGHC
13
Gilder Gagnon Howe & Co
New York
$144M 1,210,422 -6,945 -0.6%
BB
14
BB Biotech
Switzerland
$120M 1,011,338 -40,000 -4%
Goldman Sachs
15
Goldman Sachs
New York
$120M 1,010,738 -176,806 -15%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$108M 908,046 +819,160 +922%
Norges Bank
17
Norges Bank
Norway
$95.8M 803,963 +61,702 +8%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$91.1M 765,344 +17,698 +2%
1WCM
19
12 West Capital Management
New York
$83.4M 700,000 – –
PAMU
20
Pictet Asset Management (UK)
United Kingdom
$76.9M 646,038 +292,564 +83%
AG
21
Artal Group
Luxembourg
$71.5M 600,000 +150,000 +33%
BM
22
Bridger Management
New York
$65.5M 549,632 +49,413 +10%
First Trust Advisors
23
First Trust Advisors
Illinois
$63.9M 536,667 -34,731 -6%
Janus Henderson Group
24
Janus Henderson Group
United Kingdom
$60.1M 504,311 +10,692 +2%
Mitsubishi UFJ Trust & Banking
25
Mitsubishi UFJ Trust & Banking
Japan
$58.5M 491,101 +41,446 +9%
1
2 3 4 5